Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS

Sebastian Lopez-Chiriboga; Sean J. Pittock; Brian G. Weinshenker; John J. Chen; Eoin Flanagan

doi:10.1016/j.msard.2019.06.037

Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS

Sebastian Lopez-Chiriboga, Sean J. Pittock, Brian G. Weinshenker, John J. Chen, Eoin Flanagan

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	34-35
Number of pages	2
Journal	Multiple Sclerosis and Related Disorders
Volume	35
DOIs	https://doi.org/10.1016/j.msard.2019.06.037
State	Published - Oct 2019

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1016/j.msard.2019.06.037

Cite this

@article{685cbb8476304491bd5c815921cf29a7,

title = "Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS",

author = "Sebastian Lopez-Chiriboga and Pittock, {Sean J.} and Weinshenker, {Brian G.} and Chen, {John J.} and Eoin Flanagan",

note = "Funding Information: EPF is a site principal investigator in a randomized placebo-controlled clinical trial of Inebilizumab (A CD19 inhibitor) in neuromyelitis optica spectrum disorders funded by MedImmune/Viela Bio.",

year = "2019",

month = oct,

doi = "10.1016/j.msard.2019.06.037",

language = "English (US)",

volume = "35",

pages = "34--35",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier",

}

TY - JOUR

T1 - Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS

AU - Lopez-Chiriboga, Sebastian

AU - Pittock, Sean J.

AU - Weinshenker, Brian G.

AU - Chen, John J.

AU - Flanagan, Eoin

N1 - Funding Information: EPF is a site principal investigator in a randomized placebo-controlled clinical trial of Inebilizumab (A CD19 inhibitor) in neuromyelitis optica spectrum disorders funded by MedImmune/Viela Bio.

PY - 2019/10

Y1 - 2019/10

UR - http://www.scopus.com/inward/record.url?scp=85068497673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068497673&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2019.06.037

DO - 10.1016/j.msard.2019.06.037

M3 - Letter

C2 - 31299419

AN - SCOPUS:85068497673

SN - 2211-0348

VL - 35

SP - 34

EP - 35

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

ER -

Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this